Venmax Drugs & Pharmaceuticals has confirmed compliance by submitting a certificate from its Registrar and Share Transfer Agent, CIL Securities Limited.

This document attests to the company's adherence to required procedures for handling investor shares and dematerialization requests for the quarter ended June 30. This process is crucial for maintaining accurate shareholder records and ensuring the efficient processing of share transfers, which underpins investor confidence and operational integrity.